King AB - Search Results

1

Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study.

King AB. King AB. Diabetes Obes Metab. 2009 Jan;11(1):69-71. doi: 10.1111/j.1463-1326.2008.01014.x. Diabetes Obes Metab. 2009. PMID: 19120433 Clinical Trial.

2

Lipid response to pioglitazone in diabetic patients: clinical observations from a retrospective chart review.

King AB, Armstrong DU. King AB, et al. Diabetes Technol Ther. 2002;4(2):145-51. doi: 10.1089/15209150260007354. Diabetes Technol Ther. 2002. PMID: 12079617

3

A comparison of basal insulin delivery: continuous subcutaneous insulin infusion versus glargine.

King AB, Armstrong D. King AB, et al. Diabetes Care. 2003 Apr;26(4):1322. doi: 10.2337/diacare.26.4.1322. Diabetes Care. 2003. PMID: 12663626 Clinical Trial. No abstract available.

4

A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy.

Gross TM, Kayne D, King A, Rother C, Juth S. Gross TM, et al. Diabetes Technol Ther. 2003;5(3):365-9. doi: 10.1089/152091503765691848. Diabetes Technol Ther. 2003. PMID: 12828818 Clinical Trial.

5

Exploring methods to extend the reach of diabetes specialist expertise into primary care clinics.

King A, Wolfe G, Healy S, Lineham T, Harrison S, Ponzio C, Armstrong D. King A, et al. Diabetes Educ. 2006 Jul-Aug;32(4):525-30. doi: 10.1177/0145721706290831. Diabetes Educ. 2006. PMID: 16873590

6

Evaluation of a patient education booklet (SimpleStart) effect on postprandial glucose control in type 2 diabetes.

King AB, Wolfe GS, Armstrong DU. King AB, et al. Diabetes Technol Ther. 2007 Jun;9(3):241-5. doi: 10.1089/dia.2006.0014. Diabetes Technol Ther. 2007. PMID: 17561794 Clinical Trial.

7

Basal bolus dosing: a clinical experience.

King AB, Armstrong DU. King AB, et al. Curr Diabetes Rev. 2005 May;1(2):215-20. doi: 10.2174/1573399054022794. Curr Diabetes Rev. 2005. PMID: 18220597 Review.

8

Evaluation of a diabetes specialist-guided primary care diabetes treatment program.

King AB, Wolfe GS. King AB, et al. J Am Acad Nurse Pract. 2009 Jan;21(1):24-30. doi: 10.1111/j.1745-7599.2008.00370.x. J Am Acad Nurse Pract. 2009. PMID: 19125892 Clinical Trial.

9

Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used.

King AB. King AB. Endocr Pract. 2009 Apr;15(3):229-33. doi: 10.4158/EP.15.3.229. Endocr Pract. 2009. PMID: 19364691 Clinical Trial.

10

A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Basal dosing.

King AB, Armstrong DU. King AB, et al. J Diabetes Sci Technol. 2007 Jan;1(1):36-41. doi: 10.1177/193229680700100106. J Diabetes Sci Technol. 2007. PMID: 19888377 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results